Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

195P - Radiomics and dosiomics signature from whole lung predicts radiation pneumonitis : A model development study with prospective external validation and decision-curve analysis

Date

03 Apr 2022

Session

Poster Display session

Topics

Tumour Site

Thoracic Malignancies

Presenters

Zhen Zhang

Citation

Annals of Oncology (2022) 33 (suppl_2): S117-S121. 10.1016/annonc/annonc858

Authors

Z. Zhang1, Z. Wang2, A. Dekker3, L. Wee2

Author affiliations

  • 1 Maastro Clinic, Maastricht/NL
  • 2 Maastro, Maastricht/NL
  • 3 Maastro, 6202 AZ - Maastricht/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 195P

Background

Radiation pneumonitis (RP) is one of the common side effects of radiotherapy in the thoracic region. Radiomics and dosiomics quantifies information implicit within medical images and radiotherapy dose distributions. In this study we demonstrated the prognostic potential of radiomics, dosiomics, and clinical features for RP prediction.

Methods

Radiomics, dosiomics, dose-volume histogram (DVH) metrics, and clinical parameters were obtained on 314 retrospectively-collected and 35 prospectively-enrolled patients diagnosed with lung cancer between 2013 to 2019. A radiomics risk score (R-score) and dosiomics risk score (D-score) and DVH-score were calculated based on logistic regression after feature selection. Seven models were built using different combinations of R-score, D-score, and clinical parameters to evaluate their added prognostic power. The DVH model was built as a classical model for comparison with the dosiomics model. Over-optimism was evaluated by bootstrap resampling from the training set, and the prospectively-collected cohort was used as the external test set. Model calibration and decision-curve characteristics of the best-performing models were evaluated. For ease of further evaluation, nomograms were constructed for selected models.

Results

A model built by integrating all of R-score, D-score, and clinical parameters had the best discriminative ability with area under the curves (AUCs) of 0.793 (95%CI 0.735-0.851),0.774 (95%CI 0.762-0.786), and 0.855 (95%CI 0.719-0.990) in the training set, bootstrapping set, and external test set, respectively. The results of the calibration curve and decision curve analysis showed that the final model of the nomogram has potential for future clinical application. Table: 195P

Model Train (95%CI) Validation by bootstrapping (95%CI) Testing (95%CI)
R-score 0.676 (0.606-0.745) 0.619 (0.592-0.646) 0.671 (0.558-0.899)
D-score 0.728 (0.665-0.790) 0.687 (0.667-0.706) 0.684 (0.573-0.883)
DVH-score 0.637 (0.570-0.705) 0.628 (0.613-0.642) 0.661 (0.551-0.856)
Clinical parameters 0.664 (0.594-0.735) 0.654 (0.628-0.680) 0.709 (0.509-0.91)
R-score + D-score 0.735 (0.673-0.796) 0.729 (0.720-0.736) 0.739 (0.553-0.926)
R-score + C 0.717 (0.652-0.782) 0.701 (0.683-0.719) 0.771 (0.585-0.962)
D-score + C 0.770 (0.710-0.830) 0.755 (0.744-0.765) 0.756 (0.559-0.954)
R-score + D-score + C 0.793 (0.735-0.851) 0.774 (0.762-0.786) 0.855 (0.719-0.990)

Conclusions

Radiomics and dosiomics features have potential to assist with the prediction of RP.

Legal entity responsible for the study

Zhen Zhang.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.